When.com Web Search

  1. Ads

    related to: fanapt vs risperdal cost free range price

Search results

  1. Results From The WOW.Com Content Network
  2. Iloperidone - Wikipedia

    en.wikipedia.org/wiki/Iloperidone

    Iloperidone is indicated for the treatment of schizophrenia and mania or mixed episodes in bipolar I disorder. [2] [3] In a 2013 study in a comparison of 15 antipsychotic drugs in effectivity in treating schizophrenic symptoms, iloperidone demonstrated mild effectiveness — as effective as lurasidone, and 13 to 15% less effective than ziprasidone, chlorpromazine, and asenapine. [4]

  3. Antipsychotic - Wikipedia

    en.wikipedia.org/wiki/Antipsychotic

    Iloperidone (Fanapt) ... Risperidone (Risperdal) ... There have also been substantial price rises. Risperidone 6 mg tablets, the largest, increased from £3.09 in ...

  4. Prescription drug prices in the United States - Wikipedia

    en.wikipedia.org/wiki/Prescription_drug_prices...

    The price of a new drug (in most cases) is limited so that the cost of therapy with the new drug is in the range of the costs of therapy with existing drugs in the same therapeutic class. The price of a breakthrough drug is limited to the median of its prices in France, Germany, Italy, Sweden, Switzerland, Britain, and the United States.

  5. America’s Most Admired Lawbreaker - The Huffington Post

    highline.huffingtonpost.com/miracleindustry/...

    Another goal for the coming year was to “maximize and grow Risperdal’s market leadership in geriatrics and long term care.” Risperdal was already well ahead of Zyprexa in dementia market share, with 50 percent of the entire market. The goal was to boost that share still higher, to 57 percent, with sales of $302 million.

  6. FDA approves new pain medication as an alternative to opioids ...

    www.aol.com/news/fda-approves-pain-medication...

    The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

  7. NAmerica - highline.huffingtonpost.com

    highline.huffingtonpost.com/miracleindustry/...

    Risperdal. Scenario: Risperdal will lose market leadership in <: 2000 in the schizophrenia segment in US/Eu down to 30 to 40% of SDA market. Depending on the total market growth (12% /10% US I Eu to 20% US Eu), the Risperdalloss would range between 78 and 220 min US$ in the year 2000.